TN2011000262A1 - Hemifumarate salt of 1-[4-(cyclohexyl-3-trifluoromethyl-benzyloxymino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acid - Google Patents
Hemifumarate salt of 1-[4-(cyclohexyl-3-trifluoromethyl-benzyloxymino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acidInfo
- Publication number
- TN2011000262A1 TN2011000262A1 TN2011000262A TN2011000262A TN2011000262A1 TN 2011000262 A1 TN2011000262 A1 TN 2011000262A1 TN 2011000262 A TN2011000262 A TN 2011000262A TN 2011000262 A TN2011000262 A TN 2011000262A TN 2011000262 A1 TN2011000262 A1 TN 2011000262A1
- Authority
- TN
- Tunisia
- Prior art keywords
- ethyl
- trifluoromethyl
- cyclohexyl
- benzyl
- carboxylic acid
- Prior art date
Links
Abstract
This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this salt, to processes for forming this salt and to its use in medical treatment. In addition, the present invention also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TN2011000262A TN2011000262A1 (en) | 2011-05-23 | 2011-05-23 | Hemifumarate salt of 1-[4-(cyclohexyl-3-trifluoromethyl-benzyloxymino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TN2011000262A TN2011000262A1 (en) | 2011-05-23 | 2011-05-23 | Hemifumarate salt of 1-[4-(cyclohexyl-3-trifluoromethyl-benzyloxymino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2011000262A1 true TN2011000262A1 (en) | 2012-12-17 |
Family
ID=54696173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TN2011000262A TN2011000262A1 (en) | 2011-05-23 | 2011-05-23 | Hemifumarate salt of 1-[4-(cyclohexyl-3-trifluoromethyl-benzyloxymino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acid |
Country Status (1)
Country | Link |
---|---|
TN (1) | TN2011000262A1 (en) |
-
2011
- 2011-05-23 TN TN2011000262A patent/TN2011000262A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO2894B1 (en) | New salt and crystalline forms | |
IL260297A (en) | Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide | |
PH12014502789A1 (en) | N-alkyltriazole compounds as lpar antagonists | |
UA110310C2 (en) | Compounds n-aryl triazole as antagonists receptors lisophosphatidic acid (lpar) | |
NZ708501A (en) | Treatment of pulmonary disease | |
WO2014028589A3 (en) | 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
WO2015031564A3 (en) | Substituted-1h-benzo[d]imidazole compounds as lysine-specific demethylase 1 (lsd1 ) inhibitors | |
TN2014000138A1 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
PH12014502586A1 (en) | Novel ring-substituted n-pyridinyl amides as kinase inhibitors | |
MX343753B (en) | Neprilysin inhibitors. | |
JO3510B1 (en) | Use of glycopyrrolate for treating tachycardia | |
PH12015501239A1 (en) | Oral care products comprising tetrabasic zinc chloride and trimethylglycine | |
UA109867C2 (en) | Substituted pyrazole compounds as antagonists lysophosphatidic acid receptors (lpar) | |
WO2013061004A8 (en) | Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases | |
PH12018501575A1 (en) | Indolinones compounds and their use in the treatment of fibrotic diseases | |
NZ705813A (en) | Treatment of mild and moderate alzheimer’s disease | |
EA201391586A1 (en) | 17α-HYDROXYLASE / C-LIAZ INHIBITORS | |
TN2011000262A1 (en) | Hemifumarate salt of 1-[4-(cyclohexyl-3-trifluoromethyl-benzyloxymino)-ethyl]-2-ethyl-benzyl]-a zetidine-3-carboxylic acid | |
MX2015006807A (en) | METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)- N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXA MIDE AND CRISTAL FORMS THEREOF. | |
TN2013000023A1 (en) | Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases |